The Pharmacokinetics of Epidural Lidocaine and Bupivacaine During Cesarean Section

We studied the maternal pharmacokinetics of epidural lidocaine and bupivacaine in 20 healthy parturients with institutional review board approval and written, informed consent.Epidural anesthesia was induced using either 2% lidocaine with epinephrine 1:200,000, n = 10, or 0.5% plain bupivacaine, n = 10. Maternal arterial (Ma) blood was sampled at regular intervals and umbilical venous (Uv) blood at delivery. Results for lidocaine and bupivacaine, respectively, were (mean +/- SEM): age 30.4 +/- 1.5 and 24.7 +/- 1.6 yr; weight 74.0 +/- 4.2 and 74.9 +/- 4.5 kg; duration of surgery 55.5 +/- 4.3 and 53.1 +/- 3.5 min; epidural dosage 6.1 +/- 0.6 and 1.5 +/- 0.2 mg/kg; elimination half-life 113.9 +/- 5.6 and 110.4 +/- 20.4 min; plasma clearance 6.1 +/- 0.4 and 13.6 +/- 1.3 mL [centered dot] kg-1 [centered dot] min-1; volume of distribution 0.98 +/- 0.1 and 1.67 +/- 0.3 L/kg; time to peak concentration 31 +/- 2.3 and 40.5 +/- 1.7 min; peak Ma concentration 6.4 +/- 0.65 and 0.8 +/- 0.1 micro g/mL; and Uv/Ma gradient 0.43 +/- 0.05 and 0.26 +/- 0.1. Peak Ma lidocaine concentrations in 2 of 10 patients reached potentially toxic levels without producing clinical toxicity, whereas peak bupivacaine Ma concentrations never approached levels considered unsafe. The results suggest that epidural bupivacaine reliably produces acceptable Ma concentrations below the toxic range. (Anesth Analg 1997;84:527-32)

[1]  J. Downing,et al.  Bupivacaine Transfer across the Human Term Placenta: A Study Using the Dual Perfused Human Placental Model , 1995, Anesthesiology.

[2]  W R Gillespie,et al.  Noncompartmental Versus Compartmental Modelling in Clinical Pharmacokinetics , 1991, Clinical pharmacokinetics.

[3]  H. Nolte,et al.  [The concentration of free lidocaine in arterial, central venous and peripheral vein plasma following intravenous injection]. , 1990, Regional-Anaesthesie.

[4]  M. Finster,et al.  Adverse Effects of Maternally Administered Lidocaine on the Asphyxiated Preterm Fetal Lamb , 1989, Anesthesiology.

[5]  J. Saitoh,et al.  Effect of epinephrine concentration on lidocaine disposition during epidural anesthesia. , 1988, Anesthesiology.

[6]  Michael J. Cousins,et al.  Neural Blockade in Clinical Anesthesia and Management of Pain , 1988 .

[7]  A. Burm,et al.  Epidural Anesthesia with Lidocaine and Bupivacaine: Effects of Epinephrine on the Plasma Concentration Profiles , 1986, Anesthesia and analgesia.

[8]  G. Hartman,et al.  NEUROMUSCULAR AND CARDIOVASCULAR EFFECTS OF RANITIDINE HCl , 1986 .

[9]  J. Krischer,et al.  Obstetric Anesthesia: A National Survey , 1986, Anesthesiology.

[10]  B. Sibai,et al.  The Pharmacokinetics and Maternal and Neonatal Effects of Epidural Lidocaine in Preeclampsia , 1986, Anesthesia and analgesia.

[11]  L. Jenkins,et al.  Epidural blockade for cesarean section comparing lidocaine hydrocarbonate and lidocaine hydrochloride. , 1985, Anesthesiology.

[12]  F. Follath,et al.  Determination of bupivacaine in plasma by high-performance liquid chromatography. , 1984, Anesthesia and analgesia.

[13]  B. Covino,et al.  Comparative CNS Toxicity of Lidocaine, Etidocaine, Bupivacaine, and Tetracaine in Awake Dogs Following Rapid Intravenous Administration , 1983, Anesthesia and analgesia.

[14]  R. Jorden Local anesthetics and their current clinical use: Mather L, Cousins M, Drugs 18:185, (Sep) 1979 , 1980 .

[15]  G A Albright,et al.  Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. , 1979, Anesthesiology.

[16]  J. Miller,et al.  Dynamics of Local‐Anesthetic Compounds in Regional Anesthesia , 1977, Anesthesia and analgesia.

[17]  G. Tucker,et al.  The effects of adding adrenaline to etidocaine and lignocaine in extradural anaesthesia II: Pharmacokinetics. , 1976, British journal of anaesthesia.

[18]  Mather Le,et al.  Pharmacology of local anaesthetic agents. Pharmacokinetics of local anaesthetic agents. , 1975 .

[19]  G. Tucker,et al.  Pharmacology of local anaesthetic agents. Pharmacokinetics of local anaesthetic agents. , 1975, British journal of anaesthesia.

[20]  F. Reynolds A comparison of the potential toxicity of bupivacaine, lignocaine and mepivacaine during epidural blockade for surgery. , 1972, British journal of anaesthesia.

[21]  F. Reynolds A COMPARISON OF THE POTENTIAL TOXICITY OF BUPIVACAINE, LIGNOCAINE AND MEPIVACAINE DURING EPIDURAL BLOCKADE FOR SURGERY , 1971 .

[22]  G. Tucker Determination of bupivacaine (Marcaine) and other anilide-type local anesthetics in human blood and plasma by gas chromatography. , 1970, Anesthesiology.

[23]  F. Reynolds,et al.  Maternal and neonatal blood concentrations of bupivacaine , 1970, Anaesthesia.

[24]  D. Scott,et al.  Dosage of lignocaine in epidural block in relation to toxicity. , 1967, British journal of anaesthesia.

[25]  P. Lund,et al.  A Correlation of the Differential Penetration and the Systemic Toxicity of Lidocaine, Mepivacaine and Prilocaine in Man , 1966, Acta anaesthesiologica Scandinavica. Supplementum.

[26]  R. Mazze,et al.  Plasma Lidocaine Concentrations After Caudal, Lumbar Epidural, Axillary Block, and Intravenous Regional Anesthesia , 1966, Anesthesiology.

[27]  D. Scott,et al.  DOSAGE OF LIGNOCAINE IN EPIDURAL BLOCK IN RELATION TO TOXICITY , 1966 .